GE | |||||
NEWS | |||||
GE Stock Is Up Because the Tide Is Turning The further General Electric moves away from its historical write-downs and bad acquisitions, the more willing new long-term investors are to take a ...
| |||||
Here's Why General Electric Stock Is Soaring That said, GE highlighted the following factors as being responsible for the increase in FCF guidance at the midpoint of $1 billion from the second ...
| |||||
Why Shares of General Electric Are Up Today Shares of General Electric (NYSE:GE) traded up more than 4.5% on Monday as Wall Street continues to digest -- and applaud -- the industrial ...
| |||||
GE Shelves Plans to Spin-Off Digital Business GE will retain its lucrative digital business—not spin it off, as had been planned—but it will sharpen the division's focus on four key markets, including ...
| |||||
Bullish Momentum May Push GE's Stock Sharply Higher GE's stock is breaking out, and it may head towards $12.35 based on the chart. The PE ratio is currently historical high. The stock will need higher ...
| |||||
BBAM and GE Aviation Sign Asset Transfer System Agreement for Leasing Market AUSTIN, Texas--(BUSINESS WIRE)--. Leased Asset Documents Streamlined with Digital Records and Project Management System. GE Aviation has ...
| |||||
General Electric: It's The 'Story' That Really Matters General Electric reported Q3 2019 results that beat the top- and bottom-line estimates. The operating results were well-received by the market but I ...
| |||||
Investors may reconsider GE amid 'clear signs of progress,' analyst says General Electric (GE +4.9%) surges to its highest since late February as Wall Street analysts continue to weigh in on the company after gaining more ...
| |||||
Should You Be Worried About General Electric Company's (NYSE:GE) 2.2% Return On Equity? Over the last twelve months General Electric has recorded a ROE of 2.2%. One way to conceptualize this, is that for each $1 of shareholders' equity it ...
| |||||
FDA OKs new GE contrast agent The FDA approves GE Healthcare's (GE +4.3%) Clariscan (gadoterate meglumine), a gadolinium-based contrast agent used MRI imaging in brain, ...
| |||||
WEB | |||||
GE Healthcare announces US FDA approval of macrocyclic MRI contrast agent Clariscan Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar